Human parainfluenza viruses: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{Human parainfluenza virus}}
{{Human parainfluenza virus}}
{{CMG}}
{{CMG}}
==[[Human parainfluenza viruses overview|Overview]]==
==[[Human parainfluenza viruses historical perspective|Historical Perspective]]==
==[[Human parainfluenza viruses classification|Classification]]==
==[[Human parainfluenza viruses pathophysiology|Pathophysiology]]==
==[[Human parainfluenza viruses causes|Causes]]==
==[[Human parainfluenza viruses differential diagnosis|Differentiating Human parainfluenza viruses from other Disorders]]==
==[[Human parainfluenza viruses epidemiology and demographics|Epidemiology and Demographics]]==
==[[Human parainfluenza viruses risk factors|Risk Factors]]==
==[[Human parainfluenza viruses natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==Diagnosis==
[[Human parainfluenza viruses history and symptoms|History and Symptoms]] | [[Human parainfluenza viruses physical examination|Physical Examination]] | [[Human parainfluenza viruses laboratory findings|Laboratory Findings]] | [[Human parainfluenza viruses chest x ray|Chest X Ray]] | [[Human parainfluenza viruses other imaging findings|Other Imaging Findings]] | [[Human parainfluenza viruses other diagnostic studies|Other Diagnostic Studies]]
==Treatment==
[[Human parainfluenza viruses medical therapy|Medical Therapy]] | [[Human parainfluenza viruses prevention|Prevention]] | [[Human parainfluenza viruses cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Human parainfluenza viruses future or investigational therapies|Future or Investigational Therapies]]





Revision as of 19:35, 26 September 2012

Transmission electron micrograph of parainfluenza virus. Two intact particles and free filamentous nucleocapsid

Human parainfluenza viruses Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Human parainfluenza viruses from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Human parainfluenza viruses On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Human parainfluenza viruses

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Human parainfluenza viruses

CDC on Human parainfluenza viruses

Human parainfluenza viruses in the news

Blogs on Human parainfluenza viruses

Directions to Hospitals Treating Human parainfluenza viruses

Risk calculators and risk factors for Human parainfluenza viruses

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Human parainfluenza viruses from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies


Template:Jb1 Template:WH Template:WS